Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,502 | 7,755 | 11,287 | 12,193 | 11,093 |
| Marketable Securities | N/A | N/A | 0 | 3,503 | 11,427 |
| Inventories | N/A | N/A | 103 | 1,407 | 2,472 |
| Other current assets | 8 | 0 | 822 | 303 | 99 |
| TOTAL | $7,443 | $10,992 | $13,424 | $18,971 | $27,260 |
| Non-Current Assets | |||||
| PPE Net | 2,749 | 3,320 | 10,301 | 11,014 | 11,693 |
| Other Non-Current Assets | 391 | 419 | 2,497 | 2,648 | 4,217 |
| TOTAL | $3,140 | $3,739 | $12,798 | $13,662 | $15,910 |
| Total Assets | $10,583 | $14,731 | $26,222 | $32,633 | $43,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,914 | N/A | N/A |
| Accounts payable and accrued liabilities | 851 | 442 | 905 | 2,618 | 1,565 |
| Accrued Expenses | 179 | 178 | 134 | 689 | 313 |
| Other current liabilities | 49,053 | 47,740 | 800 | 900 | 800 |
| TOTAL | $60,352 | $58,198 | $13,313 | $10,008 | $8,241 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,136 | 2,848 | 2,848 | 2,970 | 2,450 |
| Other Non-Current Liabilities | 21,500 | 24,779 | 12,513 | 16,475 | 15,537 |
| TOTAL | $24,566 | $28,191 | $81,758 | $86,535 | $86,596 |
| Total Liabilities | $84,918 | $86,389 | $95,071 | $96,543 | $94,837 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,751 | 21,751 | 19,570 | 19,445 | 19,423 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -435,632 | -432,270 | -429,252 | -423,814 | -411,364 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -1 |
| TOTAL | $-74,335 | $-71,658 | $-68,849 | $-63,910 | $-51,667 |
| Total Liabilities And Equity | $10,583 | $14,731 | $26,222 | $32,633 | $43,170 |